STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012

NCT ID: NCT05767138

Last Updated: 2023-03-14

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 301 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2011-03-31
• Study Completion Date: 2011-06-30

Brief Summary

Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.

Conditions

HPV; HPV-Related Cervical Carcinoma

Study Design

• Observational Model Type: ECOLOGIC_OR_COMMUNITY
• Study Time Perspective: PROSPECTIVE

Study Groups

Bamako Participants

301 male and female participants. Teenagers and adults. Living in two urban regions of Bamako.

HPV Vaccine Acceptance Survey

Intervention Type: BEHAVIORAL

Interventions

HPV Vaccine Acceptance Survey

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• 12-17 years of age, with guardian consent
• 18 years or older
• Male or Female
• Living in Mèkin-Sikoro and Djikoroni

Exclusion Criteria

• 12-17 years of age, without guardian consent
• <12 years of age
• Living outside Mèkin-Sikoro and Djikoroni

• Minimum Eligible Age: 12 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role: collaborator

Global Alliance to Immunize Against AIDS Vaccine Foundation

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Anne De Groot, MD

Role: PRINCIPAL_INVESTIGATOR

GAIA Vaccine Foundation

Provided Documents

Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form

View Document

Other Identifiers

HPV Vaccine Survey

Identifier Type: -

Identifier Source: org_study_id